Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1016 | 1088 | 995 | 960 | 1831 | - |
Fund Return | 1.57% | 8.77% | -0.55% | -1.35% | 12.86% | - |
Place in category | 463 | 419 | 481 | 151 | 40 | - |
% in Category | 57 | 53 | 60 | 22 | 8 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Manulife TEDA Trsfmtn Opportunity E | 4.31B | 40.01 | -13.85 | - | ||
MANULIFE TEDA Market Value Selectio | 1.52B | 19.63 | -2.88 | 5.48 | ||
TEDA Value Optimization Growth Ind | 1.35B | 44.21 | -11.19 | 7.90 | ||
MANULIFE TEDA Industry Selected | 675.49M | 0.49 | -7.14 | 8.20 | ||
TEDA Value Optimization Cycle Ind | 627.72M | 9.83 | -9.09 | 12.06 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
HuaShang New Trend Selected mix | 10.3B | 10.67 | 7.86 | 21.80 | ||
Fullgoal New Power Alloc C | 5.45B | -7.42 | -7.98 | - | ||
Fullgoal New Power Alloc A | 5.45B | -7.03 | -7.51 | - | ||
QHKY New Economy Flexible Alloc Fd | 5.15B | -3.92 | -15.10 | 8.28 | ||
Soochow Mobile Internet mix A | 4.66B | 37.18 | 11.13 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Chaozhou Three-circle | CNE100001Y42 | 6.74 | 36.21 | -0.19% | |
Shandong Pharm | CNE000001BG9 | 4.97 | 24.23 | -1.10% | |
Xinfengming Group | CNE100002RH0 | 4.47 | 10.90 | +0.09% | |
Yoke Technology A | CNE100000PG0 | 4.33 | 63.59 | -1.29% | |
Shenzhen Mindray Bio-Medical | CNE100003G67 | 3.24 | 260.93 | -3.02% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Sell | Buy |
Technical Indicators | Strong Sell | Strong Buy | Neutral |
Summary | Neutral | Neutral | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review